Rob Lowe opened up to PEOPLE about his late grandmother’s breast cancer journey and her success in a clinical trial. He’s now ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

President Donald Trump said he plans to order a cut in prescription drug costs to bring them in line with other countries, ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

EXCLUSVE: LA-based production company Jingletown will be in Cannes to discuss a slate of projects including films produced ...

Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head clinical trial, according to findings published in The New England ...